Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Nuria Revilla
Deciphering Predictive Factors for Choice of Thrombopoietin Receptor Agonist, Treatment Free Responses, and Thrombotic Events in Immune Thrombocytopenia
Scientific Reports
Multidisciplinary
Transient Desialylation in Combination With a Novel Antithrombin Deficiency Causing a Severe and Recurrent Thrombosis Despite Anticoagulation Therapy
Scientific Reports
Multidisciplinary
Related publications
Switching Thrombopoietin Receptor Agonist Treatments in Patients With Primary Immune Thrombocytopenia
Therapeutic Advances in Hematology
Hematology
Eltrombopag: An Update on the Novel, Non-Peptide Thrombopoietin Receptor Agonist for the Treatment of Immune Thrombocytopenia
Annals of Hematology
Medicine
Hematology
The Emergence of Thrombopoietin Receptor Agonists as a Novel Treatment for Immune Thrombocytopenia
European Oncology and Haematology
Oncology
Hematology
Use of Thrombopoietin Receptor Agonists in Childhood Immune Thrombocytopenia
Frontiers in Pediatrics
Child Health
Pediatrics
Perinatology
PP025 Thrombopoietin Receptor Agonist for Treatment of Adults With Chronic Immune Thrombocytopenic Purpura
International Journal of Technology Assessment in Health Care
Health Policy
Eltrombopag, a Thrombopoietin- Receptor Agonist in the Treatment of Adult Chronic Immune Thrombocytopenia: A Review of the Efficacy and Safety Profile
Therapeutic Advances in Hematology
Hematology
Thrombopoietin Receptor Agonists for the Treatment of Inherited Thrombocytopenia
Haematologica
Hematology
Thrombopoietin Level Predicts Response to Treatment With Eltrombopag and Romiplostim in Immune Thrombocytopenia
American Journal of Hematology
Hematology
Thrombopoietin Receptor Agonists in Treatment of Idiopathic Thrompocytopenic Purpura (Primary Immune Thrombocytopenia): Efficacy and Safety in Everyday Clinical Practice
Klinicheskaya Onkogematologiya/Clinical Oncohematology
Oncology
Hematology
